Entering text into the input field will update the search result below

Cerus secures capital

Jul. 01, 2014 11:57 AM ETCerus Corporation (CERS) StockBy: Douglas W. House, SA News Editor
  • Cerus (NASDAQ:CERS +2.9%) consummates a $30M growth capital credit facility with Oxford Finance LLC. The company received $10M yesterday and has the option of drawing another $10M upon FDA approval of the Intercept Blood System for either platelets or plasma. The approval will trigger the last $10M tranche which will be available at Cerus' option between July 1, 2015 and December 31, 2015.

Recommended For You

More Trending News

About CERS Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
CERS--
Cerus Corporation
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.